11 results
The first aim of the present study is to examine whether the pain experience in adults with Down syndrome (without dementia) differs from the pain experience in adults without intellectual disability, after correction for mentale age, comorbidity…
The aim is to study if Neurofeedback can be an applicable intervention.for survivors of childhood brain tumours. The QEEG wil be investigated whether under or overactive brainareas exist which can be trained. This study will also investigate whether…
This hypothesis will be challenged in five objectives:1. To check the factorial validity of two cognitive styles - weak central coherence; poor cognitive shifting - in patients with MR and ASS.2. To assess the specificity of the association between…
Based on the scientific background and knowledge as detailed above this clinical proof-of-mechanism study is performed in order to determine if PET imaging with [18F]DPA-714 has the diagnostic potential to discriminate probable AD patients from…
AimThe aim of this study is to determine if WMFA measured by DTI at 3T MRI in cancer survivors is a suitable biomarker in children between 8 -16 years of age for treatment induced neurotoxicity and related neurocognitive deficits.
The aim of this study is to investigate the hypothesis that persons with ASS may be less capable of 'reading' the behavior of others and because of that they may be less capable of complying to others, leading to social and/or behavioral…
The primary objective of this study is to identify the neural correlates of language functions and, in particular, abnormal pragmatic communication in autistic spectrum disorders.
With this study, we aim to shed light on the possible use of diagnostic next generation sequencing in DLD, by determining the diagnostic yield of WGS in this important class of neurodevelopmental disorder. In addition to determining this diagnostic…
The primary objective of the diagnostic study is to analyze the CSF measurements of β-Amyloid (1-42) (Aβ 42) and Phospho-Tau (181P) (pTau) using Elecsys β-Amyloid (1-42) CSF II and Elecsys Phospho-Tau (181P) CSF in the screening samples of the phase…
The primary objectives are to investigate multiple aspects of FDM in patients with AD, MCI and PD compared to healthy controls and to investigate whether FDM problems in these patients can be related to specific neurocognitive dysfunctions. The…
With this study we aim to define a detailed oral motor, speech and language profile for patients with SAS.